HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 06-25-2007, 05:23 PM   #1
kareneg
Senior Member
 
Join Date: Nov 2005
Location: Lincoln, Rhode Island
Posts: 371
Unhappy I have a bad feeling

Hi,
I had an appointment with the doctor today and I am so confused. My Tumor Ca 27-29 is now 60 from 282, so I though the catscan would be better. I have copied word for word the report of the ct scan, I don't know how to take this. I asked my doctor how the lesion on my pancreas was and he said it was the same but the report is different. Any input will be greatly apprieciated! her is the report.

In the abdomen, the diffuse fatty infiltration is less prominent than on the prior examination but these appear to have increased in number in the interval. For example,on image 77 of series 2 there are four lesions measuring up to 2.7 cm in diameter which are clearly visualized compared to a single lesion on the prior examination. On image 82 of series 2 there are three lesions seen in segment 2 compared to a single lesion on the prior examination. On image 82 of series 2 there are three lesions seen in segment 2 compared to a single lesion on the prior examination and these lesions range from 2 to 3.2 cm in diameter. New large lesions are seen in segment 4B of the liver on images 96 and 103. The former measures 1.8 cm in diameter and the latter measures 3.4 cm in diameter. There are new calcifications visualized just above the gallbladder fossa as well as calcifications seen in segmant 7 and 8 on the prior examination. These likely are due to prior treated tumor. There is no periportal lynphadenopathy seen and the portal caval lymph node seen on the prior examonation are not clearly or discretly visualized here. The hypodense lesion in the tail of the pancreas is seen on image 99 od seris 2 and has increased in size to 3.0 x 2.3 cm.There is no dilation of the pancreatic duct. The portaland splenic veins remain patent although the splenic vein appers attenuated as it passes posterior to the pancreatic tail mass.




<HR style="MARGIN-TOP: 10px">See what's free at AOL.com.
__________________
Love and Hope
Karen

IDC
DX 1998 STAGE I ER+/ PR+
AC CHEMO TILL FEB 1999
Tamxofin till 2001
2001 exstensive liver mets and mets to lungs
Started weekly taxol
Jan 2002 found out I was strongly HER2POS+++ started herceptin continued with taxol and herceptin till June 2002 then from June 2002 till Jan 2005 just herceptin and Arimidex
2005 Navelbine herceptin had RFA Then back on taxol with herceptin
April 2006 progression again went on clinical trial with tykrerb/herceptin progressed on the started Xeloda/ herceptin
Feb 2007 started Doxil
August 2007 Taxotere,Carboplatin and Herceptin exstensive mets to liver and pancreas
October 2007 Had to stop Carboplatin due to sever allergic reaction
Jan 2008
Stopped Taxotere due to progression now on Gemzar and Herceptin
March 2008 Starting Carboplatin, Abraxane, and Herceptin.
kareneg is offline   Reply With Quote
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 12:11 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter